BG Bunge Global SA
Idea Generation
Universe screening from 50+ companies down to a target recommendation via systematic filters.
Long List
0
Short List
0
Target
N/A
IDEA GENERATION
Global Agribusiness, Oilseed Processing & Grain Trading
Lead Idea: BG — Bunge Global SA
2026-05-26
1. Screening Universe & Methodology
The agribusiness investable universe spans four sub-segments: (i) bulk traders and oilseed processors (the ABCD oligopoly — ADM, Bunge, Cargill, Louis Dreyfus — plus Wilmar, Olam, COFCO); (ii) specialty ingredients and food (Ingredion, McCormick, Kerry); (iii) renderers and renewable-diesel feedstock (Darling, Renewable Energy Group); (iv) adjacent ag-input plays (Corteva, Nutrien, Mosaic, CF, Deere, AGCO). Direction: long-biased given EPA RFS mandates and EUDR compliance moat for incumbents. Market cap floor: $1B. Style: blend of value (ADM, ANDE) and growth-at-reasonable-price (BG, INGR). Geography: US-listed and US-OTC-listed names with full disclosure.
1.1 Screens Applied
- Quantitative value: EV/EBITDA < 12x, P/B < 2x, dividend yield > 2%.
- Quality: through-cycle ROE > 8%, FCF positive 4 of last 5 years (BG fails on TTM due to Viterra WC build).
- Catalyst-driven: synergy ramp (BG), turnaround (ADM), specialty pivot (INGR).
- Thematic: renewable-diesel feedstock demand pull (BG, ADM, DAR), EUDR compliance moat (BG, ADM).
- Short candidates: post-merger integration failure risk (BG-Viterra), RD margin collapse spillover (DAR).
2. Long List — Ag-Commodity & Adjacent Universe
Ticker | Name | Mcap $B | Thesis |
BG | Bunge Global | 23 | Post-Viterra ABCD #2; LatAm + softseed diversification; synergies ahead of plan |
ADM | Archer-Daniels-Midland | 32 | ABCD #3; Nutrition platform diversifies cyclicality; turnaround post-2023 accounting probe |
WLMIY | Wilmar International | 21 | Asia/palm focused ABCD-equivalent; India growth via Adani Wilmar; Indonesia regulatory overhang |
INGR | Ingredion | 8 | Specialty starches + Texture & Healthful Solutions; higher-margin pivot from commodity |
DAR | Darling Ingredients | 4 | Renderer + Diamond Green Diesel JV; RD margin compression (FY25 EBITDA $0.21/gal vs. $1+ historical) |
ANDE | Andersons | 1.5 | US grain trade + ethanol; mid-cap exposure to Midwest flows |
AGCO | AGCO Corp | 8 | Ag equipment; correlated to farm capex cycle but not commodity trade |
CTVA | Corteva | 47 | Seeds + crop protection; upstream input supplier; defensive growth profile |
NTR | Nutrien | 33 | World's largest potash + nitrogen producer; commodity-cycle exposed |
MOS | Mosaic | 11 | Phosphate + potash; pure fertilizer cycle play |
CF | CF Industries | 16 | Pure-play nitrogen / urea; natgas-linked cost structure; clean ammonia optionality |
DE | Deere & Co | 115 | Ag equipment leader; precision farming tech; farm-income cycle exposed |
TSN | Tyson Foods | 20 | Protein processor downstream; beef/chicken/pork margins |
BG (US listed) | Olam Group / SALIC (priv.) | n/a | Olam Agri sold to SALIC Apr-26 at $4.0B equity; ofi remains |
3. Shortlist One-Pagers
3.1 BG — Bunge Global SA
Rating: Lead idea — initiate now
Thesis pillars:
- Post-Viterra scale event: merger closed Jul-2025 created world's #2 grain/oilseed trader (after private Cargill, ahead of ADM); >$100B revenue run-rate, 50K+ employees, 300+ storage, 40+ port terminals, 155+ processing facilities.
- Synergy ramp ahead of plan: $190M synergies realized FY 2026, target $250M run-rate by 2027 (mgmt has track record of beating Viterra synergy guides since deal close).
- Best-in-class Latin American origination: complements Viterra's Canada/Australia softseed (canola, sunflower) for true global softseed + soybean coverage — most diversified ABCD geographic exposure.
- US crush footprint benefits directly from EPA RFS 2026/27 soybean-oil pull: structural demand floor under soybean oil at 4.86B gal/yr renewable diesel; US 2025/26 crush record 2.55-2.57B bushels.
- Guidance raised twice this year: 2026 adj. EPS guide moved from $7.50-8.00 to $9.00-9.50 after strong Q1 2026 (adj. EPS $1.83 beat consensus $0.87 by 110%).
Key metrics:
Mcap | Rev | EBITDA | Net | Beta |
$23.4B | TTM $80.5B | $2.23B | inc $0.69B | 0.63 |
Key risks:
- Brazil 2025/26 record crop + 2026/27 even larger → multi-year price compression
- US-China soybean trade fragility (only 10.6 MMT of 12 MMT commitment booked through Feb-26)
- Viterra integration risk (culture, IT, $9.8B debt assumption)
- S. American crush margin compression (Brazil utilization down, Argentina at <55%)
- Diamond Green Diesel-style RD margin collapse
Next steps:
Initiation report — full coverage with DCF, comps, 3-statement model, thesis tracker, catalyst calendar.
3.2 ADM — Archer-Daniels-Midland
Rating: Secondary — value/turnaround
Thesis pillars:
- Beaten down post 2023 accounting investigation; trading ~14x EV/EBITDA vs. 10-yr median 10.3x (multiple expansion off trough EBITDA).
- 2026 adj. EPS guide $3.60-4.25 implies recovery from 2025 $3.43 (-44% YoY); Nutrition platform organically growing mid-single.
- Cheaper on absolute basis than BG but lacks Viterra-style catalyst; less Latin American exposure.
- Ag Services & Oilseeds margin recovery path is the bull case; Nutrition margin expansion is the diversification angle.
Key metrics:
Mcap | P/E | Fwd | EV/EBITDA | ROIC |
$32B | 36.0x | P/E 15.2x | 14.2x | ~7% |
Key risks:
- 2023 accounting hangover
- Lower crush margins than competitors
- Less LatAm exposure than BG
- Nutrition organic growth deceleration
Next steps:
Watch — initiate only if BG fully under coverage; would be complementary long-short pair within ABCD.
3.3 INGR — Ingredion
Rating: Secondary — specialty pivot
Thesis pillars:
- FY25 revenue $7.22B; 50% starches + 34% sweeteners + 16% Texture & Healthful Solutions.
- Texture & Healthful Solutions growing mid-single, structurally higher-margin (15-18% EBIT vs. 8-10% for commodity).
- Lower commodity cycle exposure than ABCD; closer to packaged-food cycle.
- Trades 8.7x EV/EBITDA vs. 9.0x 10-yr median — fair value but not catalyst-rich.
Key metrics:
Mcap | P/E | EV/EBITDA | ROIC | Specialty |
$8B | 13.0x | 8.7x | ~10% | mix growing |
Key risks:
- Corn/grain price volatility
- Customer concentration in CPG
- Mexico operations expansion risk
Next steps:
Watch — would be entry into specialty ingredient niche if BG thesis plays out.
3.4 DAR — Darling Ingredients
Rating: Cautious — RD margin collapse
Thesis pillars:
- Renderer + 50% JV in Diamond Green Diesel (Valero JV).
- FY25 DGD EBITDA collapsed to $0.21/gal vs. $1+/gal historical — RD producer-level margin compression is the key sector signal.
- If RD margin compression spreads to feedstock (soy oil) values, would be bearish for BG/ADM crush spreads too.
- Pure-play RD upside if mandate-driven demand reasserts; pure-play downside if margins stay compressed.
Key metrics:
Mcap | Net | DGD | Fwd | Net |
$4B | inc $0.063B FY25 | EBITDA $104M (-64% YoY) | P/E 28x | sales $6.1B |
Key risks:
- RD margin compression structural
- Feedstock cost volatility
- Tax credit (45Z) policy risk
Next steps:
Watch as macro signal for soy-oil demand health. Pair short candidate if BG bear case develops.
3.5 CTVA — Corteva
Rating: Watch — upstream play
Thesis pillars:
- Seeds + crop protection; FY25 revenue ~$17B.
- Less commodity-cycle exposed than ABCD (charges by acre, not by ton).
- Beneficiary of farm-income cycle and biotech adoption in LatAm.
- Different valuation framework (specialty-ag vs. commodity trader) — not direct comp but related universe.
Key metrics:
Mcap | P/E | EV/EBITDA | Op | FCF |
$47B | 23x | 11x | margin 14% | yield ~4% |
Key risks:
- Glyphosate litigation overhang
- Patent cliff on key herbicide
- China generic competition
Next steps:
Watch — initiation candidate if expanding coverage to ag inputs.
4. Shortlist Comparison Matrix
Ticker | Sub-segment | Mcap $B | Fwd P/E | EV/EBITDA | Conviction | Action |
BG | Post-Viterra ABCD #2 | 23 | 15.1x | 12.6x | HIGH | Initiate now |
ADM | ABCD #3 — turnaround | 32 | 15.2x | 14.2x | MED | Watch — pair candidate |
INGR | Specialty starches | 8 | 12.5x | 8.7x | MED | Watch — specialty pivot |
DAR | Renderer + DGD JV | 4 | 28.0x | 10.5x | LOW | Watch — RD signal |
CTVA | Seeds + crop protection | 47 | 21x | 11x | LOW | Watch — ag input |
5. Why BG is the Lead Initiation
Bunge combines four characteristics that no other US-listed ABCD/agribusiness name fully replicates:
- Post-merger scale event: only public ABCD player with a fresh accretive M&A catalyst (Viterra closed Jul-2025); synergy ramp ahead of plan.
- Best-in-class Latin American origination + Viterra's Canada/Australia softseed = most diversified ABCD geographic mix; ADM and Wilmar each tilt one geography.
- Direct beneficiary of EPA RFS 2026/27 soy-oil pull: US crush footprint expanding at record 2.55-2.57B bu vs. 3.0B installed capacity (12 new plants + 5 expansions adding 1.46M bu/day pipelined).
- Guidance momentum: management raised 2026 adj. EPS guide twice this year ($7.50→$9.00-9.50) on Viterra synergies + LatAm origination strength — clear positive revisions pattern.
ADM is the natural pair candidate but lacks BG's catalyst freshness; INGR sits in a different (higher-margin, lower-cyclical) niche; DAR is a sector signal more than an investment; CTVA is an upstream input play with a different valuation framework. BG sits at the intersection of (a) the cleanest M&A integration catalyst in the sector, (b) the largest beneficiary of the structural RD-driven soybean-oil demand pull, and (c) the most globally diversified ABCD geographic footprint. Initiation will quantify whether the 12.6x EV/EBITDA multiple — already 64% above the 10-yr median — already prices in the Viterra synergy ramp and whether the $9.00-9.50 EPS guide is defensible against the record Brazilian crop and South American crush margin compression.
DISCLAIMER: For institutional / educational use only. Not investment advice. Sources: Yahoo Finance, company 10-K/10-Q, USDA WASDE, EPA RFS, Reuters, S&P Global, DTN, Pitchbook, NOAA.
Datos Estructurados
Fuente: Yahoo Finance, SEC EDGAR, Damodaran, Company Filings